Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis
Siddhartha Kar(University of Cambridge), George S. Vassiliou(Wellcome/MRC Cambridge Stem Cell Institute), Tao Jiang(Beijing University of Technology), Clea Bárcena(Universidad de Oviedo), Jonathan Mitchell(AstraZeneca (United Kingdom)), Margarete A. Fabre(AstraZeneca (United Kingdom)), Muxin Gu(Wellcome/MRC Cambridge Stem Cell Institute), Vivek Iyer(Wellcome Sanger Institute), Paul Carter(University of Cambridge), Ryan Langdon(Centre international de recherche sur le cancer), Stephen Burgess(University of Cambridge), Pedro M. Quirós(Universidad de Oviedo), Slavé Petrovski(AstraZeneca (United Kingdom)), M. S. Vijayabaskar(Wellcome/MRC Cambridge Stem Cell Institute)
Cited by 355
Related Papers
Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator
|Genetic Epidemiology|2016|9.5k
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k
Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants
|Epidemiology|2016|2.1k
A review of instrumental variable estimators for Mendelian randomization
|Statistical Methods in Medical Research|2015|1.9k
Guidelines for performing Mendelian randomization investigations
|Wellcome Open Research|2020|1.3k